ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

AGRANULOCYTOSIS ASSOCIATED WITH TRANDOLAPRIL-VERAPAMIL COMBINATION

Journal: International Journal of Hematology and Therapy (Vol.2, No. 1)

Publication Date:

Authors : ;

Page : 1-3

Keywords : Agranulocytosis; Trandolapril-Verapamil Combination;

Source : Downloadexternal Find it from : Google Scholarexternal

Abstract

A number of medications have been implicated as potential causes of severe neutropenia or agranulocytosis. A 66-year-old female patient was administered with verapamil-trandolapril for treatment of hypertension. Over three years of verapamil- trandolapril treatment, neutropenia developed. Verapamil-trandolapril was switched to amlodipine and white blood cell count recovered within two months. After a while, amlodipine was switched to ramipril because of the pretibial edema (a side effect of amlodipine); over thirty days neutropenia developed once again. Agranulocytosis is rarely seen due to angiotensin converting enzyme (ACE) inhibitors. Therefore, physicians should be aware of the potential side effects of ACE inhibitors and their combinations on blood cells (especially neutrophils), particularly in patients treated for a long time.

Last modified: 2017-01-09 17:52:12